Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc LXXGQ

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Post by TanzaniteMotherLodeon Jun 14, 2021 9:10am
187 Views
Post# 33380774

Thursday June 17th

Thursday June 17thLastly, on Thursday, June 17, Dr. Regan will be a featured speaker at the 28th International Biothreat and Pathogen Detection Conference. His presentation, Rapidly Configurable Automate Multiplexed Pathogen Detection System for Novel Threat Detection, will focus on the ability of the MiQLab to be easily configured to detect multiple pathogens in a single sample as a critical measure in biosurveillance activities. Examples of MiQLab’s applications for biothreat surveillance and diagnostics will be featured. Registration is still available for those wanting to watch the presentation. LexaGene anticipates issuing a news release on the day of the conference to disclose any data to be presented.
<< Previous
Bullboard Posts
Next >>